Carla leads global digital, R&D, and regulatory policy for Johnson & Johnson’s Government Affairs & Policy (GA&P) policy team across the pharmaceutical and medical device sectors. Regularly convening and leading cross functional teams on key issues including AI and diversity in clinical research, Carla collaborates with partners in legal, privacy, commercial, regulatory affairs, and supply chain. She represents GA&P in several internal fora including the Johnson & Johnson Data Science and Data Management Councils and external groups like IFPMA and HIMSS. Her team is responsible for the development of J&J’s social and economic footprints and efforts in support of the R&D ecosystem. Carla was previously a part of the Federal Affairs team where she led FDA related advocacy and supported the oncology and immunology portfolios and worked for J&J Innovative Medicine’s Global Regulatory Policy and Intelligence team where she was the US policy lead on topics including clinical trial innovation, patient engagement, expedited approval pathways, disease interception, and combination products. Prior to joining Johnson & Johnson, Carla was an attorney and team leader in FDA's Office of the Chief Counsel where she advised the Center for Drug Evaluation and Research on legal and policy issues, working closely with the Offices of Policy and Legislation. Living in Kensington MD with her spouse and teenage son, Carla enjoys traveling, baking, trying to keep her many plants alive, and book clubs. She serves on the board of the Educational Foundation for her son’s school. Carla is a graduate of Washington University in St. Louis and has a JD from Yale Law School and an LLM from Georgetown University Law Center.